PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) Regimen as Second-Line Therapy in Patients With Progressive or Recurrent Pancreatic Cancer After Gemcitabine-Containing Chemotherapy-Reference-Cited by-同舟云学术

PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) Regimen as Second-Line Therapy in Patients With Progressive or Recurrent Pancreatic Cancer After Gemcitabine-Containing Chemotherapy

Published:2008-04 Issue:2 Volume:31 Page:145-150
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Reni M,Cereda S,Mazza E,Passoni P,Nicoletti R,Balzano G,Zerbi A,Arcidiacono P G.,Staudacher C,Di Carlo V

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference26 articles.

1. No standard treatment is available for advanced pancreatic cancer.;Lionetto;Eur J Cancer,1995

2. Should further studies of chemotherapy be carried out in pancreatic cancer?;Taylor;Eur J Cancer,1993

3. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer.;Glimelius;Ann Oncol,1996

4. Chemotherapy prolongs survival in inoperable pancreatic cancer.;Palmer;Br J Surg,1994

5. Improvement in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.;Burris;J Clin Oncol,1997

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world outcomes of cisplatin, capecitabine, and gemcitabine with either epirubicin (PEXG) or docetaxel (PDXG) as first‐line palliative treatment in metastatic or unresectable locally advanced pancreatic adenocarcinoma;Asia-Pacific Journal of Clinical Oncology;2022-09-16

2. Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX;Anticancer Research;2020-07

3. Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?;Critical Reviews in Oncology/Hematology;2017-07

4. Pancreatic ductal adenocarcinoma: metastatic disease;Clinical and Translational Oncology;2017-06-16

5. Use of gemcitabine as a second-line treatment following chemotherapy with folfirinox for metastatic pancreatic adenocarcinoma;Oncology Letters;2017-04-20